AMDL, Inc. Promotes CFO Akio Ariura to Chief Operating Officer and Expands Management Team
November 06 2008 - 9:30AM
PR Newswire (US)
TUSTIN, Calif., Nov. 6 /PRNewswire-FirstCall/ --
(http://www.amdl.com/) AMDL, Inc. (AMEX:ADL), today announced the
promotion of its CFO, Mr. Akio Ariura, to Chief Operating Officer
(COO) and CFO. The Company is also expanding its management team
with the addition of Mr. Christopher Gee as Director of
International Marketing and Sales and Mr. Raymond Gatchalian as
Director of Compliance and Information Technology. As COO and CFO,
Mr. Ariura will lead the day-to-day operations of AMDL, including
direct responsibility for AMDL's legal, financial, and business
affairs; employee development and recruiting; and high-priority
companywide initiatives, including the implementation of its
Kingdee ERP accounting system within the US and China; joint
venture and partnership implementations; and the development of
brand and product commercialization strategies across all business
divisions. "I am extremely pleased with the Board's decision to
promote Akio to Chief Operating Officer of AMDL," said Mr. Douglas
MacLellan, CEO and Chairman, AMDL. "He has been instrumental in the
Company's success to date, and broadening his role is a next step
as we continue to grow and expand our business. With the support of
his leadership and business expertise, AMDL is on-target to meet
its gross revenue targets of $30 million to $38 million this year.
I'm genuinely excited to have Akio in this newly created senior
executive position as we focus on building AMDL as a world-class
and market-leading, diversified pharmaceutical company." Mr. Ariura
joined AMDL in 2006 as the Chief Financial Officer. He holds more
than 20 years of experience in senior finance and business
operations positions with various public and private companies. Mr.
Ariura is a certified public accountant and recognized as a
Small-Cap SOX compliance expert. "I'm pleased to transition to this
role during such a defining time in AMDL's history. With nearly
500% annual growth over the past three years we've managed to
thrive and evolve, despite market uncertainty and recent economic
instability," commented Mr. Ariura. "In fact, what I am most proud
of is how we've continued to expand our sales and distribution
throughout China, with top-line sales that far exceed goals set
during our 2007 planning cycle." AMDL is also expanding its senior
management team with the appointment of Mr. Christopher Gee as
Director of International Marketing and Sales and Mr. Raymond
Gatchalian as Director of Compliance and Information Technology.
Mr. MacLellan continued, "This latest round of executive
appointments further complements the top-notch team we have
assembled. They are highly qualified, dedicated professionals with
the depth of experience and professional tenure to help take AMDL
to the next level. I'm pleased to welcome Chris and Ray aboard."
Mr. Gee is a former Apple Inc. executive and tech/biotech industry
veteran with extensive IT, business operations, and international
sales and marketing management experience. Since 2004 he has held
executive positions and worked on projects in the USA, PRC China,
Hong Kong, and Taiwan including IT management, product development,
marketing, sales and distribution. His oversight spanned US and
Asian business operations. His background includes three years as a
senior analyst at New York University, Stern School of Business.
Mr. Gee has also been a principal in various start-up companies.
While at Apple Inc., Mr. Gee successfully managed business
development and enterprise computing projects. Mr. Gee holds a
Masters degree from Kings College, University of London and a
Bachelors degree from New York University. Mr. Gatchalian has an
extensive background in IT audit and compliance. He has worked for
both large and small companies including Pacificare Health Systems,
Corinthian Colleges and Fremont Investment and Loan and as a
consultant with Deloitte & Touche, Jefferson Wells, Countrywide
Financial and Diagnostics Products International, with the primary
responsibility of planning, conducting and managing system audits
and providing consulting services to various IT organizations. Mr.
Gatchalian received his B.S. in Computer Information Systems from
the DeVry Institute of Technology. About AMDL: Headquartered in
Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China,
AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc.
(JPI), is a vertically integrated bio-pharmaceutical company
devoted to the research, development, manufacturing, and marketing
of diagnostic, pharmaceutical, nutritional supplement, and cosmetic
products. The company employs approximately 320 people in the U.S.
and China. The Company has an additional 4 pharmaceutical and
diagnostic products under review by various regulatory authorities.
Forward Looking Statements: Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995: The statements contained
in this document include certain predictions and projections that
may be considered forward- looking statements under securities law.
These statements involve a number of important risks and
uncertainties that could cause actual results to differ materially
including, but not limited to, the performance of joint venture
partners, as well as other economic, competitive and technological
factors involving the Company's operations, markets, services,
products, and prices. With respect to AMDL, Inc., except for the
historical information contained herein, the matters discussed in
this document are forward-looking statements involving risks and
uncertainties that could cause actual results to differ materially
from those in such forward-looking statements. Potential risks and
uncertainties related to the Company's access to additional
capital, competition and dependence on key management. AMDL
Contact: Kristine Szarkowitz Director-Investor Relations (M) (206)
310-5323 DATASOURCE: AMDL, Inc. CONTACT: Kristine Szarkowitz,
Director-Investor Relations of AMDL, +1-206-310-5323, Web site:
http://www.amdl.com/
Copyright
Amdl (AMEX:ADL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amdl (AMEX:ADL)
Historical Stock Chart
From Jul 2023 to Jul 2024